HQ Function

Served as the primary center for research and development, corporate operations, and strategic planning for Neoleukin's de novo protein design and immunotherapy programs prior to its acquisition by Neurogene Inc.

Notable Features:

Located in a modern office building within Seattle's biotech cluster, facilitating collaboration and access to a skilled talent pool. Specific architectural details are not widely publicized.

Work Culture:

Prior to its acquisition, Neoleukin fostered a scientifically driven, innovative, and collaborative work environment. The culture was focused on pioneering de novo protein design to tackle complex diseases, emphasizing cutting-edge research and teamwork.

HQ Significance:

The Seattle headquarters was central to Neoleukin's identity and operations, enabling its advanced research in protein design and immunotherapy development within one of the leading U.S. biotech ecosystems.

Values Reflected in HQ: The headquarters and its operations likely reflected values of innovation, scientific rigor, patient-focus, and collaboration, essential for a biopharmaceutical company developing novel therapeutics.

Location:

As a focused biopharmaceutical company primarily based in Seattle, Neoleukin Therapeutics' global presence prior to its acquisition was mainly through scientific collaborations, potential clinical trial sites for its programs, and engagement with the international scientific and investment communities. It did not operate extensive independent global offices.

Street Address:

188 E Blaine St, Suite 450

City:

Seattle

State/Province:

WA

Country:

USA